文献速递腹部介入CT

胰腺癌CT:依据NCCN标准预测可切除性

Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
PubMed 文献 · Radiology · 2018-09-25

回顾性分析616例胰腺癌患者的结构化CT报告,按NCCN标准(1.2017版)评估可切除性并预测R0切除。371例手术患者中,可切除、交界可切除、不可切除的R0切除率分别为73%、55%、16%(P < .001)。可切除患者中肿瘤大于4 cm和门肠系膜静脉接触与切缘阳性相关。

要点

  • 按NCCN标准CT可切除性分层可预测R0切除:可切除73%、交界可切除55%、不可切除16%(P < .001)。
  • 可切除患者中肿瘤大于4 cm和门肠系膜静脉接触与切缘阳性切除显著相关(均P < .001)。
  • 可切除且无门肠系膜静脉接触者R0切除率80%,有接触者59%;肿瘤≤2 cm者83%,大于4 cm者29%。

核心结论

  • CT可切除性可用于按R0切除可能性对胰腺癌患者进行分层;肿瘤较大及门肠系膜静脉接触与可切除胰腺癌的切缘阳性切除相关。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2017年3月经委员会认证腹部放射科医师临床准备的结构化胰腺CT报告,共616例胰腺癌患者(男369例、女247例;平均年龄63岁±10[标准差]),按NCCN标准(1.2017版)评估可切除性。

诊断标准与关键数值

  • 在371例手术患者中,R0切除率按CT可切除状态分别为:可切除73%(171/235)、交界可切除55%(57/104)、不可切除16%(5/32)(P < .001)。多变量分析显示,可切除患者中肿瘤直径大于4 cm(P < .001)和门肠系膜静脉接触(P < .001)与切缘阳性切除显著相关。R0切除率:可切除且无门肠系膜静脉接触80%(123/154),可切除且有门肠系膜静脉接触59%(48/81),可切除且肿瘤≤2 cm 83%(57/69),肿瘤大于4 cm 29%(5/17)。

临床应用与阅片要点

  • 作者指出,CT可切除性可用于按R0切除可能性对胰腺癌患者进行分层;可切除患者中肿瘤大于4 cm和门肠系膜静脉接触与切缘阳性切除相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the diagnostic performance of CT in the determination of pancreatic cancer resectability according to the National Comprehensive Cancer Network (NCCN) criteria to predict R0 resection. Materials and Methods Structured reports of pancreatic CT clinically prepared by board-certified abdominal radiologists from January 2014 to March 2017 were retrospectively reviewed to assess resectability (resectable, borderline resectable, or unresectable) according to NCCN criteria (version 1.2017) in 616 patients (369 men, 247 women; mean age, 63 years ± 10 [standard deviation]) with pancreatic cancer. Negative resection margin (R0) rates were assessed based on CT resectability status in patients who underwent upfront surgery. R0 resection-associated factors were identified by using logistic regression analysis. Results In 371 patients who underwent surgery, R0 resection rates were 73% (171 of 235), 55% (57 of 104), and 16% (five of 32) for resectable, borderline resectable, and unresectable disease, respectively (P < .001). At multivariable analysis, tumor diameter larger than 4 cm (P < .001) and abutment to the portomesenteric vein (P < .001) were significantly associated with margin-positive resection in patients with resectable disease at CT. R0 resection rates were 80% (123 of 154) for resectable disease without portomesenteric vein abutment, 59% (48 of 81) for resectable disease with portomesenteric vein abutment, 83% (57 of 69) for resectable disease 2 cm or smaller, and 29% (five of 17) for tumors larger than 4 cm. Conclusion CT resectability is used to stratify patients with pancreatic cancer according to the possibility of R0 resection. Larger tumor size and tumor abutment to the portomesenteric vein are associated with margin-positive resection in patients with resectable pancreatic cancer. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Fowler in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Hong SB, Lee SS, Kim JH, et al. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Radiology. 2018. PMID: 30251929. doi:10.1148/radiol.2018180628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。